Illumina Jumps into Cancer Screening with $100 Million Spin-off Grail
Updated:
7 Sep 2020
The DNA sequencing giant will launch a new company, Grail, to develop blood tests to detect cancer.
Add to your Fliist
Add
Grail: Risky, but if works, big breakthrough in broad spectrum EARLY cancer detection. Brilliant scientists.
Open FLIIST
0
Share
